treosulfan has been researched along with Local Neoplasm Recurrence in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Bassermann, F; Braitsch, K; Götze, KS; Herhaus, P; Hubbuch, M; Keller, U; Koch, K; Menzel, H; Schwarz, A; Verbeek, M | 1 |
| Bertz, H; Bornhäuser, M; Burchert, A; Dreger, P; Finke, J; Glass, B; Grishina, O; Hegenbart, U; Kobbe, G; Reicherts, C; Schmoor, C; Schub, N; Sohlbach, K; Stelljes, M; Wagner-Drouet, EM | 1 |
| Shimoni, A | 1 |
| Amit, O; Avivi, I; Chemnitz, JM; Hallek, M; Holtick, U; Moshe, Y; Ram, R; Scheid, C; Wolf, D | 1 |
| Forsyth, S; Michelagnoli, M; Whelan, J | 1 |
| Lane, G; Montes, A; Seshadri, S; Wuntakal, R | 1 |
| du Bois, A; Gropp, M; Kimmig, R; Kuhn, W; Lück, HJ; Meier, W; Olbricht, S; Pfisterer, J; Reuss, A; Richter, B | 1 |
| Markman, M | 1 |
| Belau, A; Fuxius, S; Heidrich-Lorsbach, E; Heuser, T; Klare, P; Kölbl, H; Mahner, S; Markmann, S; Oskay-Özcelik, G; Ruhmland, B; Sehouli, J; Sommer, H | 1 |
| Allerton, R; Cree, IA; Di Nicolantonio, F; Knight, LA; Kurbacher, CM; Lamont, A; Neale, MH; Osborne, RJ; Skailes, GE | 1 |
| Bojko, P; Dirsch, O; Hilger, RA; Ruehm, SG; Scheulen, ME; Seeber, S | 1 |
| Atzpodien, J; Fluck, M; Reitz, M; Terfloth, K | 1 |
| Gropp, M; Hepp, H; Meier, W | 1 |
| Baumgart, J; Hilger, RA; Jacek, G; Kredtke, S; Oberhoff, C; Scheulen, ME; Seeber, S | 1 |
| Dichgans, J; Herrlinger, U; Schmidt, F; Weller, M; Wick, W | 1 |
| Breidenbach, M; Kurbacher, CM; Mallmann, P; Rein, DT | 1 |
| Shershah, S | 1 |
1 review(s) available for treosulfan and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Busulfan; Carcinoma, Ovarian Epithelial; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Randomized Controlled Trials as Topic | 2016 |
6 trial(s) available for treosulfan and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Thiotepa-fludarabine-treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial.
Topics: Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies; Thiotepa; Transplantation Conditioning; Unrelated Donors; Vidarabine | 2022 |
A phase II study to determine the efficacy and safety of oral treosulfan in patients with advanced pre-treated Ewing sarcoma ISRCTN11631773.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Busulfan; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Salvage Therapy; Sarcoma, Ewing; Survival Rate | 2015 |
Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekolog
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Prospective Studies; Survival Rate; Topotecan | 2009 |
A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis.
Topics: Aged; Aged, 80 and over; Alopecia; Anemia; Antineoplastic Agents, Alkylating; Busulfan; Constipation; Drug Administration Schedule; Fatigue; Female; Humans; Leukopenia; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies; Quality of Life; Recurrence; Surveys and Questionnaires; Treatment Outcome | 2012 |
Treosulfan as an effective second-line therapy in ovarian cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Busulfan; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Survival Rate; Treatment Outcome | 1998 |
Treosulfan chemotherapy for recurrent malignant glioma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Astrocytoma; Bone Marrow; Brain Neoplasms; Busulfan; Cohort Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Retreatment; Salvage Therapy; Survival Analysis; Treatment Outcome | 2000 |
10 other study(ies) available for treosulfan and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis.
Topics: Aged; Busulfan; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Myeloproliferative Disorders; Neoplasm Recurrence, Local; Retrospective Studies; Transplantation Conditioning; Vidarabine | 2022 |
Treosulfan-based or busulfan-based conditioning for allogeneic transplantation: the role of dose intensity.
Topics: Busulfan; Cyclophosphamide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Transplantation, Homologous; Vidarabine | 2020 |
Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience.
Topics: Adolescent; Adult; Aged; Busulfan; Female; Germany; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Israel; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Probability; Prognosis; Retrospective Studies; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation; Young Adult | 2019 |
Chemotherapy: Topotecan or treosulfan--that is the question.
Topics: Antineoplastic Agents; Busulfan; Clinical Trials as Topic; Disease-Free Survival; Drug Resistance; Drug Therapy; Female; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Survival Analysis; Time Factors; Topotecan | 2009 |
Use of an ATP-based chemosensitivity assay to design new combinations of high-concentration doxorubicin with other drugs for recurrent ovarian cancer.
Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Doxorubicin; Drug Carriers; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Liposomes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Vinblastine; Vinorelbine | 2002 |
Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Alkylating; Busulfan; Combined Modality Therapy; Female; Femur Head Necrosis; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiography | 2003 |
Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Deoxycytidine; Female; Gemcitabine; Germany; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Uveal Neoplasms | 2008 |
Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Alkylating; Biological Availability; Busulfan; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms | 2000 |
Individualized long-term chemotherapy for recurrent ovarian cancer after failing high-dose treatment.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Treatment Failure | 2002 |
Treatment by combined chemotherapy for recurrent ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Cystadenocarcinoma; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1985 |